Lineage Cell Therapeutics (LCTX) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.025714
Actual EPS
-0.02
Surprise EPS
0.01
Surprise Percent
+22.22%

Description

⁨Lineage Cell Therapeutics⁩ (⁦LCTX⁩) has reported earnings of ⁦-0.02⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts